Takeshi Masuda

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Cancers

Thoracic cancer

Japanese journal of clinical oncology

Respirology (Carlton, Vic.)

This page only lists publications with an associated author ORCID identifier.

Publications

Keita Kawakado, Yukari Tsubata, Takamasa Hotta, Masahiro Yamasaki, Nobuhisa Ishikawa, Takeshi Masuda, Tetsuya Kubota, Kunihiko Kobayashi, Takeshi Isobe
D-dimer cut-off value for predicting venous thromboembolism at the initial diagnosis in Japanese patients with advanced lung cancer. Japanese journal of clinical oncology (2024)
Kentaro Tokumo, Takeshi Masuda, Taku Nakashima, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Yoshihiro Miyata, Morihito Okada, Hironobu Hamada, Noboru Hattori
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition. Cancers 15 (4) (2023)
Kentaro Tokumo, Takeshi Masuda, Taku Nakashima, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Yoshihiro Miyata, Morihito Okada, Hironobu Hamada, Noboru Hattori
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition. Cancers 15 (4) (2023)
Takehiro Umemura, Hirotsugu Kenmotsu, Daisuke Hazama, Shunsuke Teraoka, Hiroshi Kobe, Kazuhiko Nakagawa, Teppei Yamaguchi, Takeshi Masuda, Toshihide Yokoyama, Isamu Okamoto, Koji Haratani, Daisuke Hayakawa, Masahide Oki, Shinnosuke Takemoto, Tomohiro Ozaki, Yusaku Akashi, Akito Hata, Hiroya Hashimoto, Nobuyuki Yamamoto, Kazuhiko Nakagawa
Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single-plex testing: WJOG13620L. Cancer medicine (2023)
Takashi Oda, Hiroshi Iwamoto, Sachio Takeno, Tomohiro Kawasumi, Kota Takemoto, Manabu Nishida, Nobuyuki Chikuie, Yuichiro Horibe, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Naoko Higaki, Takayuki Taruya, Yasushi Horimasu, Takeshi Masuda, Takao Hamamoto, Taku Nakashima, Takashi Ishino, Tsutomu Ueda, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis. Medicina (Kaunas, Lithuania) 59 (10) (2023)
Kentaro Tokumo, Takeshi Masuda, Taku Nakashima, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Yoshihiro Miyata, Morihito Okada, Hironobu Hamada, Noboru Hattori
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition. Cancers 15 (4) (2023)
Takeshi Masuda, Kazunori Fujitaka, Tomoko Suzuki, Kosuke Hamai, Naoko Matsumoto, Mirai Matsumura, Shoko Isoyama, Sayaka Ueno, Mineyo Mito, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Reo Kawano, Ken Masuda, Ryohei Nishino, Nobuhisa Ishikawa, Masahiro Yamasaki, Noboru Hattori
Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1. Thoracic cancer 13 (11) (2022)
Wakako Daido, Takeshi Masuda, Nobuki Imano, Naoko Matsumoto, Kosuke Hamai, Yasuo Iwamoto, Yusuke Takayama, Sayaka Ueno, Masahiko Sumii, Hiroyasu Shoda, Nobuhisa Ishikawa, Masahiro Yamasaki, Yoshifumi Nishimura, Shigeo Kawase, Naoki Shiota, Yoshikazu Awaya, Tomoko Suzuki, Soichi Kitaguchi, Kazunori Fujitaka, Yasushi Nagata, Noboru Hattori
Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer. Cancers 14 (24) (2022)
Wakako Daido, Takeshi Masuda, Nobuki Imano, Naoko Matsumoto, Kosuke Hamai, Yasuo Iwamoto, Yusuke Takayama, Sayaka Ueno, Masahiko Sumii, Hiroyasu Shoda, Nobuhisa Ishikawa, Masahiro Yamasaki, Yoshifumi Nishimura, Shigeo Kawase, Naoki Shiota, Yoshikazu Awaya, Tomoko Suzuki, Soichi Kitaguchi, Kazunori Fujitaka, Yasushi Nagata, Noboru Hattori
Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer. Cancers 14 (24) (2022)
Wakako Daido, Takeshi Masuda, Nobuki Imano, Naoko Matsumoto, Kosuke Hamai, Yasuo Iwamoto, Yusuke Takayama, Sayaka Ueno, Masahiko Sumii, Hiroyasu Shoda, Nobuhisa Ishikawa, Masahiro Yamasaki, Yoshifumi Nishimura, Shigeo Kawase, Naoki Shiota, Yoshikazu Awaya, Tomoko Suzuki, Soichi Kitaguchi, Kazunori Fujitaka, Yasushi Nagata, Noboru Hattori
Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer. Cancers 14 (24) (2022)
Noriaki Ito, Takeshi Masuda, Ikuko Ooka, Takatsune Hosoya, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Taku Nakashima, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
First-line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptor G719S and de novo T790M mutations. Thoracic cancer 13 (5) (2022)
Hiroki Tanahashi, Kakuhiro Yamaguchi, Koji Kurose, Satoshi Nakao, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Toru Oga, Mikio Oka, Noboru Hattori
Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis. Respirology (Carlton, Vic.) (2022)
Sachiko Shioya, Takeshi Masuda, Hiroshi Iwamoto, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Taku Nakashima, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
Pulmonary lymphangitic carcinomatosis from recurrent gastric cancer 19 years after primary resection: a case report. Clinical journal of gastroenterology 14 (2) (2021)
Nobuki Imano, Tomoki Kimura, Daisuke Kawahara, Riku Nishioka, Wataru Fukumoto, Reo Kawano, Katsumaro Kubo, Tsuyoshi Katsuta, Yuki Takeuchi, Ikuno Nishibuchi, Yuji Murakami, Yasushi Horimasu, Takeshi Masuda, Kazunori Fujitaka, Noboru Hattori, Yasushi Nagata
Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients. Japanese journal of clinical oncology 51 (12) (2021)
Naokazu Watari, Kakuhiro Yamaguchi, Takeshi Masuda, Noriaki Ito, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive-stage small cell lung cancer: Two case reports. Thoracic cancer 12 (21) (2021)
Yu Wakabayashi, Takeshi Masuda, Kazunori Fujitaka, Taku Nakashima, Joe Okumoto, Kiyofumi Shimoji, Yoshifumi Nishimura, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Shinichiro Ohshimo, Hironobu Hamada, Noboru Hattori
Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non-small cell lung cancer. Cancer science 112 (1) (2020)
Takeshi Masuda, Taku Nakashima, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Yoshihiro Miyata, Hironobu Hamada, Morihito Okada, Noboru Hattori
Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts. Journal of cellular and molecular medicine 23 (4) (2019)
Yu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takahiro Mimae, Taku Nakashima, Shintaro Miyamoto, Yasuhiro Tsutani, Hiroshi Iwamoto, Kazunori Fujitaka, Yoshihiro Miyata, Hironobu Hamada, Morihito Okada, Noboru Hattori
Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer. International journal of clinical oncology 25 (1) (2019)
Kakuhiro Yamaguchi, Hiroshi Iwamoto, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis. Respirology (Carlton, Vic.) 25 (3) (2019)
Takeshi Masuda, Chihiro Hirano, Yasushi Horimasu, Taku Nakashima, Shintarou Miyamoto, Hiroshi Iwamoto, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer. Cancer chemotherapy and pharmacology 81 (1) (2017)

Takeshi Masuda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takeshi Masuda